In addition, it has been shown that FGF23, in an αKlotho-dependent manner, suppresses PTH secretion, which is reduced in CKD and that the CaSR suppressive effect is also reduced because of hyperphosphatemia-related decreased expression of the CaSR. The gene discussed is FGF23; the disease is hyperphosphatemia.